Zentiva S.A. Logo

Zentiva S.A.

Develops and distributes affordable generic, OTC, and specialty medicines across Europe.

SCD | RO

Overview

Corporate Details

ISIN(s):
ROSCDBACNOR8
LEI:
254900HN31MYF870PE70
Country:
Romania
Address:
THEODOR PALLADY, 032266 BUCUREȘTI, SECTORUL 3
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Zentiva S.A. is a pan-European pharmaceutical company focused on the development, manufacturing, and distribution of high-quality, affordable medicines. The company's extensive portfolio encompasses generic drugs, over-the-counter (OTC) products, and specialty care medicines, including biosimilars. Serving more than 100 million people across over 30 countries, Zentiva is committed to enhancing public health by increasing access to essential treatments. With a workforce of approximately 5,000 employees, the company emphasizes sustainability and social responsibility in its operations, aiming to provide health and wellbeing for all generations.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 16:49
Annual Report
Raport Financiar Trimestrial - RFT
English 550.4 KB
2025-05-15 16:47
Quarterly Report
Raport Financiar Trimestrial - RFT
Romanian 648.8 KB
2025-04-30 16:13
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 222.1 KB
2025-04-30 13:55
Annual Report
Raport Financiar Anual - RFA
English 819.1 KB
2025-04-30 13:54
Annual Report
Raport Financiar Anual - RFA
Romanian 702.8 KB
2025-02-28 10:30
Annual / Quarterly Financial Statement
REZULTATE FINANCIARE PRELIMINARE
English 262.6 KB
2025-02-28 10:29
Annual Report
REZULTATE FINANCIARE PRELIMINARE
Romanian 334.2 KB
2025-02-21 14:24
Post-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 570.2 KB
2025-02-21 14:02
Post-Annual General Meeting Information
Schimbari in conducerea societatii comerciale - RC09
Romanian 660.1 KB
2024-06-13 16:22
Related Party Transaction
Raportare tranzactii parti afiliate in conformitate cu art.92 ind.3 din Legea 2…
English 128.3 KB
2024-05-15 17:19
Quarterly Report
Raport Financiar Trimestrial - RFT
English 452.7 KB
2024-05-15 17:18
Quarterly Report
Raport Financiar Trimestrial - RFT
Romanian 467.9 KB
2024-04-29 14:28
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
English 111.4 KB
2024-04-29 11:53
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
English 123.9 KB
2024-03-21 11:05
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
English 184.0 KB

Automate Your Workflow. Get a real-time feed of all Zentiva S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Zentiva S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Zentiva S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America
APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS

Talk to a Data Expert

Have a question? We'll get back to you promptly.